Marianna Foldvari received an award for Outstanding Lifetime Achievements in Nanoscience from NanoOntario, an organization that represents the province’s nanotechnology community. She has also been appointed a fellow of the prestigious American Association of Pharmaceutical Sciences (AAPS). Dr. Foldvari is a global leader in non-invasive gene therapy and nanomedicine-based large drug molecule delivery.
Richard Houghson, Kinesiology professor and his team discover that women can process oxygen about 30% more quickly than men when they start to exercise, indicating a superior aerobic system. “It could change the way we approach assessment and athletic training down the road,” said Thomas Beltrame, lead author on the study.
The study is published in Applied Physiology, Nutrition, and Metabolism.
Technology developed by Alexander Wong and team is paving the way for artificial intelligence (AI) to break free of the internet and cloud computing.
New deep-learning AI software produced with that technology is compact enough to fit on mobile computer chips for use in everything from smartphones to industrial robots. That would allow devices to operate independent of the internet while using AI that performs almost as well as tethered neural networks.
Michael Pope, Chemical Engineering professor and collaborators are working to improve energy-storage devices known as supercapacitors. Their novel design roughly doubles the amount of electrical energy the rapid-charging devices can hold, helping pave the way for eventual use in everything from smartphones and laptop computers, to electric vehicles and high-powered lasers.
Shawn Wettig and the Wettig lab are building new types of surfactants with the aim of improving how drugs are delivered into human bodies. By exploring the different ways that molecular structures can be altered to improve effectiveness of gemini surfactants, the researchers are developing and refining methods that have many applications. Surfactants are relied on by industry for thousands of products, but the Wettig lab is particularly interested in surfactants as a mode of delivering gene therapy.